The Food and Drug Administration (FDA) on Dec. 20 approved the obesity medication Zepbound as the first pharmaceutical treatment for moderate-to-severe obstructive sleep apnea (OSA) in adults with obesity.
Obesity is a major risk factor for OSA, a condition characterized by disordered…
Zepbound Gets FDA Approval to Treat Sleep Apnea …C0NTINUE READING >>>>